INFLUVAC TETRA NH

Pays: Indonésie

Langue: indonésien

Source: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Ingrédients actifs:

A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR 180), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), B/PHUKET/3073/2013-LIKE STRAI

Disponible depuis:

ABBOTT INDONESIA - Indonesia

DCI (Dénomination commune internationale):

A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR 180), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), B/PHUKET/3073/2013-LIKE STRAI

Dosage:

15 MCG /15 MCG /15 MCG /15 MCG

forme pharmaceutique:

SUSPENSI INJEKSI

Unités en paquet:

DUS, 1 PRE-FILLED SYRINGE @ 0,5 ML (1 DOSIS)

Fabriqué par:

ABBOTT BIOLOGICALS B.V. - Netherlands

Date de l'autorisation:

2019-08-29

Résumé des caractéristiques du produit

                                DISETUJUI BPOM: 24 JULI 2023
ID REG: EREG100346VR12300091
DISETUJUI BPOM: 24 JULI 2023
ID REG: EREG100346VR12300091
                                
                                Lire le document complet
                                
                            

Afficher l'historique des documents